ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,201.54
-0.28%
Dow Jones
42,428.76
0.31%
Gold vs US Dollar
2,667.055
-0.05%
Brent Oil
79.52
-0.95%
Bitcoin
96,773.00
2.40%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. PureTech Health PLC (PRTC)

  7. PureTech Health PLC (PRTC) News

PureTech Health (PRTC)

PureTech Health PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRTC
DateTimeSourceHeadlineSymbolCompany
09/01/202512:00Business WirePureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)NASDAQ:PRTCPureTech Health PLC
08/01/202512:00Business WirePureTech to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
06/01/202507:00Business WirePureTech Appoints UBS as UK Corporate BrokerNASDAQ:PRTCPureTech Health PLC
16/12/202407:00Business WirePureTech’s Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b TrialNASDAQ:PRTCPureTech Health PLC
11/12/202412:05Business WirePureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024NASDAQ:PRTCPureTech Health PLC
09/12/202407:00Business WirePureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual MeetingNASDAQ:PRTCPureTech Health PLC
20/11/202412:05Business WirePureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of DirectorsNASDAQ:PRTCPureTech Health PLC
05/11/202412:05Business WirePureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial OfficerNASDAQ:PRTCPureTech Health PLC
30/10/202411:00Business WirePureTech to Present at Two Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
21/10/202406:00Business WirePureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing RoundNASDAQ:PRTCPureTech Health PLC
09/10/202406:00Business WirePureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual MeetingNASDAQ:PRTCPureTech Health PLC
01/10/202411:00Business WirePureTech to Present at CHEST 2024 Annual MeetingNASDAQ:PRTCPureTech Health PLC
27/09/202406:00Business WirePureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in AdultsNASDAQ:PRTCPureTech Health PLC
06/09/202406:00Business WirePureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted TherapiesNASDAQ:PRTCPureTech Health PLC
28/08/202420:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
28/08/202411:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
28/08/202406:01Business WirePureTech Health plc – Half-Year ReportNASDAQ:PRTCPureTech Health PLC
22/08/202420:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
22/08/202406:00Business WirePureTech Appoints Michele Holcomb, PhD, to Board of DirectorsNASDAQ:PRTCPureTech Health PLC
21/08/202406:00Business WirePureTech Health: Notice of Half-Yearly ResultsNASDAQ:PRTCPureTech Health PLC
13/08/202411:05Business WirePureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of DirectorsNASDAQ:PRTCPureTech Health PLC
23/07/202412:26Business WirePureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of CommercialNASDAQ:PRTCPureTech Health PLC
24/06/202416:00Business WirePureTech Health: Completion of Tender Offer & Total Voting RightsNASDAQ:PRTCPureTech Health PLC
24/06/202406:00Business WirePureTech Health: Results of the Tender OfferNASDAQ:PRTCPureTech Health PLC
20/06/202406:00Business WirePureTech Announces Change of Board RoleNASDAQ:PRTCPureTech Health PLC
18/06/202411:05Business WirePureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management TeamNASDAQ:PRTCPureTech Health PLC
13/06/202420:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
13/06/202417:15Business WirePureTech Health: Results of Annual General MeetingNASDAQ:PRTCPureTech Health PLC
06/06/202420:39Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:PRTCPureTech Health PLC
06/06/202420:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
 Showing the most relevant articles for your search:NASDAQ:PRTC

Your Recent History

TSXV
IVC.H
Interconnect Ventures
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads